A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food
Clinical trial NCT05520827 · COMPLETED
Trial details
- NCT number
- NCT05520827
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-29
- Primary completion
- 2023-03-06
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.